Carlsmed, Inc. Common Stock
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and … Read more
Carlsmed, Inc. Common Stock (CARL) - Total Assets
Latest total assets as of December 2025: $130.12 Million USD
Based on the latest financial reports, Carlsmed, Inc. Common Stock (CARL) holds total assets worth $130.12 Million USD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Carlsmed, Inc. Common Stock - Total Assets Trend (2023–2025)
This chart illustrates how Carlsmed, Inc. Common Stock’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Carlsmed, Inc. Common Stock - Asset Composition Analysis
Current Asset Composition (December 2025)
Carlsmed, Inc. Common Stock's total assets of $130.12 Million consist of 97.4% current assets and 2.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 65.9% |
| Accounts Receivable | $11.36 Million | 8.7% |
| Inventory | $1.84 Million | 1.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2023–2025)
This chart illustrates how Carlsmed, Inc. Common Stock's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Carlsmed, Inc. Common Stock's current assets represent 97.4% of total assets in 2025, an increase from 83.9% in 2023.
- Cash Position: Cash and equivalents constituted 65.9% of total assets in 2025, up from 51.5% in 2023.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2023.
- Asset Diversification: The largest asset category is accounts receivable at 8.7% of total assets.
Carlsmed, Inc. Common Stock Competitors by Total Assets
Key competitors of Carlsmed, Inc. Common Stock based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
UCrest Bhd
KLSE:0005
|
Malaysia | RM48.46 Million |
|
Vanfund Urban Investment & Development Co Ltd
SHE:000638
|
China | CN¥265.74 Million |
|
BIT Computer Co. Ltd
KQ:032850
|
Korea | ₩82.38 Billion |
|
ezCaretech Co. LTD
KQ:099750
|
Korea | ₩56.71 Billion |
|
SyntekaBio Inc
KQ:226330
|
Korea | ₩33.49 Billion |
|
Carelabs Co.Ltd
KQ:263700
|
Korea | ₩105.15 Billion |
|
Shanghai Kingstar Winning Software
SHE:300253
|
China | CN¥8.35 Billion |
|
Longmaster Information Tech
SHE:300288
|
China | CN¥1.33 Billion |
Carlsmed, Inc. Common Stock - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Carlsmed, Inc. Common Stock generates 0.39x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Carlsmed, Inc. Common Stock is currently not profitable relative to its asset base.
Carlsmed, Inc. Common Stock - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 8.87 | 5.60 | 1.58 |
| Quick Ratio | 8.74 | 5.48 | 1.50 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $112.39 Million | $ 40.53 Million | $ 4.33 Million |
Carlsmed, Inc. Common Stock - Advanced Valuation Insights
This section examines the relationship between Carlsmed, Inc. Common Stock's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.24 |
| Latest Market Cap to Assets Ratio | 0.82 |
| Asset Growth Rate (YoY) | 151.1% |
| Total Assets | $130.12 Million |
| Market Capitalization | $106.56 Million USD |
Valuation Analysis
Near Book Valuation: The market values Carlsmed, Inc. Common Stock's assets close to their book value ( 0.82x), suggesting investors view the company's assets at approximately fair value.
Rapid Asset Growth: Carlsmed, Inc. Common Stock's assets grew by 151.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Carlsmed, Inc. Common Stock (2023–2025)
The table below shows the annual total assets of Carlsmed, Inc. Common Stock from 2023 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $130.12 Million | +151.08% |
| 2024-12-31 | $51.82 Million | +269.54% |
| 2023-12-31 | $14.02 Million | -- |